Biology and clinical relevance of granulysin: REVIEW ARTICLE

Tissue Antigens

Volumn 73, Issue 3, 2009, Pages 193-198

  Krensky, A M ^a   Clayberger, C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antibiotics; Cytolytic T lymphocytes; Granulysin; Immunotherapeutics; Natural killer cells

Indexed keywords

ALPHA INTERFERON; BIOLOGICAL MARKER; CHEMOATTRACTANT; CYTOKINE; GRANULYSIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; RECOMBINANT GRANULYSIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOIMMUNE DISEASE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CHEMOTAXIS; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG BINDING; DRUG MECHANISM; EXOCYTOSIS; FUNGUS; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; INFECTION; INFLAMMATORY CELL; MICROORGANISM; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NEOPLASM; NONHUMAN; PARASITE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCTION; REVIEW; SKIN DISEASE; TRANSPLANTATION; TUMOR; TUMOR CELL DESTRUCTION; YEAST;

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CHEMOTAXIS; COMMUNICABLE DISEASES; HUMANS; IMMUNITY, CELLULAR; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NEOPLASMS; SKIN DISEASES; T-LYMPHOCYTES;

NEGIBACTERIA; POSIBACTERIA;

EID: 60649102921     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01218.x     Document Type: Review

References (50)

1. Krensky AM, Clayberger C. Granulysin: a novel host defense molecule. Am J Transplant 2005 : 5 : 1789 92.
2. Jongstra J, Schall TJ, Dyer BJ et al. The isolation and sequence of a novel gene from a human functional T cell line. J Exp Med 1987 : 165 : 601 14.
3. Pena SV, Krensky AM. Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity. Semin Immunol 1997 : 9 : 117 25.
4. Pena SV, Hanson DA, Carr BA, Goralski TJ, Krensky AM. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J Immunol 1997 : 158 : 2680 8.
5. Stenger S, Hanson DA, Teitelbaum R et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998 : 282 : 121 5.
6. Hanson DA, Kaspar AA, Poulain FR, Krensky AM. Biosynthesis of granulysin, a novel cytolytic molecule. Mol Immunol 1999 : 36 : 413 22.
7. Farouk SE, Mincheva-Nilsson L, Krensky AM, Dieli F, Troye-Blomberg M. Gamma delta T cells inhibit in vitro growth of the asexual blood stages of Plasmodium falciparum by a granule exocytosis-dependent cytotoxic pathway that requires granulysin. Eur J Immunol 2004 : 34 : 2248 56.
8. Kaspar AA, Okada S, Kumar J et al. A distinct pathway of cell-mediated apoptosis initiated by granulysin. J Immunol 2001 : 167 : 350 6.
9. Anderson DH, Sawaya MR, Cascio D et al. Granulysin crystal structure and a structure-derived lytic mechanism. J Mol Biol 2003 : 325 : 355 65.
10. Okada S, Li Q, Whitin JC, Clayberger C, Krensky AM. Intracellular mediators of granulysin-induced cell death. J Immunol 2003 : 171 : 2556 62.
11. Gamen S, Hanson DA, Kaspar A, Naval J, Krensky AM, Anel A. Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. J Immunol 1998 : 161 : 1758 64.
12. Deng A, Chen S, Li Q, Lyu SC, Clayberger C, Krensky AM. Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator. J Immunol 2005 : 174 : 5243 8.
13. Stenger S, Rosat JP, Bloom BR, Krensky AM, Modlin RL. Granulysin: a lethal weapon of cytolytic T cells. Immunol Today 1999 : 20 : 390 4.
14. Sahiratmadja E, Alisjahbana B, Buccheri S et al. Plasma granulysin levels and cellular interferon-gamma production correlate with curative host responses in tuberculosis, while plasma interferon-gamma levels correlate with tuberculosis disease activity in adults. Tuberculosis (Edinb) 2007 : 87 : 312 21.
15. Di Liberto D, Buccheri S, Caccamo N et al. Decreased serum granulysin levels in childhood tuberculosis which reverse after therapy. Tuberculosis (Edinb) 2007 : 87 : 322 8.
16. Stegelmann F, Bastian M, Swoboda K et al. Coordinate expression of CC chemokine ligand 5, granulysin, and perforin in CD8+ T cells provides a host defense mechanism against Mycobacterium tuberculosis. J Immunol 2005 : 175 : 7474 83.
17. Toro JC, Hoffner S, Linde C, Andersson M, Andersson J, Grundstrom S. Enhanced susceptibility of multidrug resistant strains of Mycobacterium tuberculosis to granulysin peptides correlates with a reduced fitness phenotype. Microbes Infect 2006 : 8 : 1985 93.
18. Andersson J, Samarina A, Fink J, Rahman S, Grundstrom S. Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis. Infect Immun 2007 : 75 : 5210 22.
19. Klucar P, Barnes PF, Kong Y et al. Characterization of effector functions of human peptide-specific CD4+ T-cell clones for an intracellular pathogen. Hum Immunol 2008 : 69 : 475 83.
20. Gansert JL, Kiessler V, Engele M et al. Human NKT cells express granulysin and exhibit antimycobacterial activity. J Immunol 2003 : 170 : 3154 61.
21. Endsley JJ, Furrer JL, Endsley MA et al. Characterization of bovine homologues of granulysin and NK-lysin. J Immunol 2004 : 173 : 2607 14.
22. Liu B, Liu S, Qu X, Liu J. Construction of a eukaryotic expression system for granulysin and its protective effect in mice infected with Mycobacterium tuberculosis. J Med Microbiol 2006 : 55 : 1389 93.
23. Ochoa MT, Stenger S, Sieling PA et al. T-cell release of granulysin contributes to host defense in leprosy. Nat Med 2001 : 7 : 174 9.
24. Zheng CF, Ma LL, Jones GJ et al. Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients. Blood 2007 : 109 : 2049 57.
25. Kishi A, Takamori Y, Ogawa K et al. Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression of cancer. Cancer Immunol Immunother 2002 : 50 : 604 14.
26. Pages F, Berger A, Camus M et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005 : 353 : 2654 66.
27. Saigusa S, Ichikura T, Tsujimoto H et al. Serum granulysin level as a novel prognostic marker in patients with gastric carcinoma. J Gastroenterol Hepatol 2007 : 22 : 1322 7.
28. Nagasawa M, Kawamoto H, Tsuji Y, Mizutani S. Transient increase of serum granulysin in a stage IVs neuroblastoma patient during spontaneous regression: case report. Int J Hematol 2005 : 82 : 456 7.
29. Sekiya M, Ohwada A, Katae M, Dambara T, Nagaoka I, Fukuchi Y. Adenovirus vector-mediated transfer of 9 kDa granulysin induces DNA fragmentation in HuD antigen-expressing small cell lung cancer murine model cells. Respirology 2002 : 7 : 29 35.
30. Sarwal MM, Jani A, Chang S et al. Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation. Hum Immunol 2001 : 62 : 21 31.
31. Kotsch K, Mashreghi MF, Bold G et al. Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation 2004 : 77 : 1866 75.
32. Hidalgo LG, Einecke G, Allanach K et al. The transcriptome of human cytotoxic T cells: measuring the burden of CTL-associated transcripts in human kidney transplants. Am J Transplant 2008 : 8 : 637 46.
33. Nagasawa M, Isoda T, Itoh S et al. Analysis of serum granulysin in patients with hematopoietic stem-cell transplantation: its usefulness as a marker of graft-versus-host reaction. Am J Hematol 2006 : 81 : 340 8.
34. Oono T, Morizane S, Yamasaki O et al. Involvement of granulysin-producing T cells in the development of superficial microbial folliculitis. Br J Dermatol 2004 : 150 : 904 9.
35. Raychaudhuri SP, Jiang WY, Raychaudhuri SK, Krensky AM. Lesional T cells and dermal dendrocytes in psoriasis plaque express increased levels of granulysin. J Am Acad Dermatol 2004 : 51 : 1006 8.
36. McInturff JE, Wang SJ, Machleidt T et al. Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes. J Invest Dermatol 2005 : 125 : 256 63.
37. Ammar M, Mokni M, Boubaker S, El Gaied A, Ben Osman A, Louzir H. Involvement of granzyme B and granulysin in the cytotoxic response in lichen planus. J Cutan Pathol 2008 : 35 : 630 4.
38. Morizane S, Suzuki D, Tsuji K, Oono T, Iwatsuki K. The role of CD4 and CD8 cytotoxic T lymphocytes in the formation of viral vesicles. Br J Dermatol 2005 : 153 : 981 6.
39. Chung WH, Hung SI, Yang JY et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008 : 14 : 1343 50.
40. King AE, Critchley HO, Kelly RW. Innate immune defences in the human endometrium. Reprod Biol Endocrinol 2003 : 1 : 116.
41. Mincheva-Nilsson L, Nagaeva O, Sundqvist KG, Hammarstrom ML, Hammarstrom S, Baranov V. gammadelta T cells of human early pregnancy decidua: evidence for cytotoxic potency. Int Immunol 2000 : 12 : 585 96.
42. Balogh GA, Russo IH, Spittle C, Heulings R, Russo J. Immune-surveillance and programmed cell death-related genes are significantly overexpressed in the normal breast epithelium of postmenopausal parous women. Int J Oncol 2007 : 31 : 303 12.
43. Qiu C, Saito S, Sakai M, Ogawa K, Nagata K, Williams MA. Plasma granulysin concentrations and preeclampsia risk. Clin Biochem 2006 : 39 : 1016 21.
44. Sakai M, Ogawa K, Shiozaki A et al. Serum granulysin is a marker for Th1 type immunity in pre-eclampsia. Clin Exp Immunol 2004 : 136 : 114 9.
45. Huang LP, Lyu SC, Clayberger C, Krensky AM. Granulysin-mediated tumor rejection in transgenic mice. J Immunol 2007 : 178 : 77 84.
46. Ma LL, Wang CL, Neely GG, Epelman S, Krensky AM, Mody CH. NK cells use perforin rather than granulysin for anticryptococcal activity. J Immunol 2004 : 173 : 3357 65.
47. Ma LL, Spurrell JC, Wang JF et al. CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15. J Immunol 2002 : 169 : 5787 95.
48. Wang Z, Choice E, Kaspar A et al. Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin. J Immunol 2000 : 165 : 1486 90.
49. da Silva AP, Unks D, Lyu SC et al. In vitro and in vivo antimicrobial activity of granulysin-derived peptides against Vibrio cholerae. J Antimicrob Chemother 2008 : 61 : 1103 9.
50. Chen X, Howe J, Andra J et al. Biophysical analysis of the interaction of granulysin-derived peptides with enterobacterial endotoxins. Biochim Biophys Acta 2007 : 1768 : 2421 31.